LP
GILD icon

LMR Partners’s Gilead Sciences GILD Stock Holding History

LMR Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-125,000
Closed -$10.1M – 1213
2023
Q4 		$10.1M Buy
+125,000
New +$9.73M 0.12% 199

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LMR Partners's GILD Position: Q2 2026 in Review

LMR Partners opened a new position in Gilead Sciences (GILD) in Q2 2026: 15,891 shares worth $2.01M. The stake represents 0.01% of the portfolio and ranks #897 among its holdings. This is a return to the name: LMR Partners previously reported a position in GILD as recently as Q4 2025.

LMR Partners first reported a position in GILD in Q2 2014 and has held it in 21 quarters since. The position peaked at $5.87M in Q2 2020. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • LMR Partners held 15,891 shares of Gilead Sciences worth $2.01M as of Q2 2026.
  • Gilead Sciences was a new LMR Partners position in Q2 2026.
  • Gilead Sciences made up 0.01% of LMR Partners's portfolio in Q2 2026, its #897 holding.
  • LMR Partners first reported a position in Gilead Sciences in Q2 2014 and has held it in 21 quarters since.
  • LMR Partners's Gilead Sciences position peaked at $5.87M in Q2 2020.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.